# Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer

> **NCT00777335** · PHASE2 · TERMINATED · sponsor: **Translational Research in Oncology** · enrollment: 4 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Panobinostat - LBH589
- **DRUG:** Panobinostat - LBH589

## Key facts

- **NCT ID:** NCT00777335
- **Lead sponsor:** Translational Research in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Very low recruitement rate.
- **Last updated:** 2015-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777335, "Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00777335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*